# Enovis Corporation (ENOV) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Industrials / Machinery. Price $18.56, market value $1.1 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Enovis Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.5×**. Each dollar of revenue is priced at 0.5×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.7×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 7.5×**. Enterprise value is 7.5× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 5.9%** (5-yr avg -0.1%). Free cash flow equals 5.9% of the market value, above its five-year average of -0.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Gross margin: 61.1%**. Enovis Corporation keeps 61.1% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -45.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -52.7%**. The company reported a net loss over the last twelve months.
- **Return on equity: -79.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -29.8%**. Return on all capital, debt included, is -29.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -28.7%**. Each dollar of assets produces -28.7% of profit.

## Growth
- **Revenue growth (1 yr): 6.7%** (3-yr 12.9%/yr, 5-yr 14.9%/yr). Revenue grew 6.7% over the last year, against 14.9% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -39.0%**. Earnings per share fell 39.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.87**. Debt is 0.87 times equity, moderate leverage.
- **Net debt / EBITDA: 4.1×**. It would take 4.1 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 0.44**. A Z-score of 0.44 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Enovis Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (12 analysts). 12 analysts cover Enovis Corporation; the consensus is strong_buy, with an average price target of $40.83 (+120% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -41.2%** (YTD -30.3%, 3-mo -22.0%). The shares are down 41.2% over twelve months including dividends.
- **From 52-week high: -45.9%** (0.2% above the low). Trading 46% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 26**. An RSI of 26 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 1.51** (volatility 62%). Beta of 1.51 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ENOV · Page: https://foliofundamentals.com/stocks/enov

Not investment advice.